Search results
Equities Analysts Issue Forecasts for Intra-Cellular Therapies, Inc.’s Q1 2024 Earnings...
ETF DAILY NEWS· 6 days agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q1 2024 earnings per share (EPS) estimates for shares of Intra-Cellular ...
Young, successful tech cofounders have a secret weapon: couples therapy
Business Insider· 2 days agoRunning a tech startup together can be highly stressful. Some cofounders have turned to couples ...
The Goldman Sachs Group Increases Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $77.00
ETF DAILY NEWS· 2 days agoThe Goldman Sachs Group currently has a neutral rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the stock. Needham & ...
Intra-Cellular Therapies (NASDAQ:ITCI) Stock Rating Reaffirmed by Needham & Company LLC
ETF DAILY NEWS· 2 days agoITCI has been the subject of several other research reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $101.00 price target on shares of Intra-Cellular Therapies in a research ...
Young, successful tech cofounders have a secret weapon: couples therapy
INSIDER via Yahoo News· 2 days agoSome cofounders go to couples therapy to learn how to navigate conflict. They say therapy improved...
Tinnitus retraining therapy: Procedure, effectiveness, and risks
Medical News Today· 3 days agoTinnitus retraining therapy (TRT) uses counseling and sound therapy to alter a negative response to...
Matt Barnes and Anansa Sims on If There's Been Infidelity In Their Relationship
popculture.com· 1 day agoMatt Barnes and Anansa Sims have a new We tv reality series, The Barnes Bunch, which chronicles...
ADUS vs. USPH: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 9 hours agoPhysical Therapy has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently...
Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $90.00 by Analysts at TD Cowen
ETF DAILY NEWS· 2 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its price objective hoisted by TD Cowen from $80.00 to $90.00 in a report issued on Wednesday morning, Benzinga reports. They currently ...
The ‘Never-Ending’ Healing Journey Of Columbine’s Survivors
Women's Health via Yahoo News· 13 hours agoAfter the 1999 mass shooting at Columbine High School, the community had to find ways to carry on....